In this episode host Ross O'Brien from Bonaventure Equity interviews Greg McKee, the founder and CEO of Journey Life Sciences and a managing partner at Bonaventure Equity. O'Brien and McKee discuss the emerging world of psychedelics and venture capital, and the need for new paradigms of medicine to address the mental health, addiction, and pain epidemics. They talk about entrepreneurship and the importance of testing the market demand for new ideas, especially in the context of psychedelics as potential therapeutics. McKee shares his background in finance and drug development, and how he came to be interested in psychedelics. The episode concludes with a discussion of Journey's mission and how the company is working to bring psychedelic therapies to market.

Produced by PodConX

Ross O'Brien - https://www.linkedin.com/in/rossobrien/

Bonaventure Equity - https://link.bve.vc/Visit-Us

Greg McKee - https://www.linkedin.com/in/gregorymmckee/